Aarey Drugs (AAREYDRUGS)
STALWARTScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹89.91 |
| Market Cap | ₹217.56 Cr |
| P/E Ratio | 63.43 |
| ROCE | 6.38% |
| ROE | 3.06% |
| Dividend Yield | 0% |
| Profit Growth | -20.83% |
| Debt/Equity | 0.38 |
| Sales Growth | -27.92% |
| Promoter Holding | 50.04% |
| 52-Week Range | ₹50.31 — ₹100 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹49.48 |
Aarey Drugs trades with a P/E ratio of 63.43, ROCE of 6.38%, ROE of 3.06%, profit growth of -20.83%, debt-to-equity of 0.38.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer